Tin tức & Cập nhật

An observational study shows an association between adjunctive clindamycin and reduced odds of mortality in children with invasive Group A streptococcal (iGAS) infections.

A short-term intervention combining sleep scheduling and use of bright-light glasses in the morning and blue light–blocking glasses in the evening can correct the circadian timing and extend weeknight sleep duration in adolescents, as shown in a study.

New drug applications approved by US FDA as of 1-15 May 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Azithromycin appears to only be as good as placebo in the treatment of preschool-age children presenting to the emergency department (ED) with moderate-to-severe acute wheezing, according to a study.

Tỷ lệ mắc các bệnh dị ứng cơ địa ở trẻ nhỏ sinh tại Hồng Kông đã tăng 46% trong đại dịch COVID-19, có thể liên quan đến sự thay đổi của hệ vi sinh đường ruột ở trẻ sơ sinh do việc khử trùng mạnh mẽ. SIM03 và SIM05, các công thức sữa chứa lợi khuẩn được phát triển với sự hỗ trợ của trí tuệ nhân tạo (AI), đã chứng minh làm giảm mức độ nặng của chàm và cải thiện chất lượng sống (QoL) ở trẻ em và người lớn, bằng cách điều hòa hệ vi sinh đường ruột.

The phase 3 trial of the selective dopamine D1 receptor antagonist ecopipam has demonstrated maintenace of tic suppression for up to 24 weeks and reduction in the risk of relapse of 50 percent in children with Tourette syndrome.

Children maintaining a sustained adherence rate of at least 85 percent to daily growth hormone therapy see a clinically meaningful improvement in growth over 2 years, as shown in a retrospective study.

Dyslipidaemia appears to be prevalent among adolescents and young men in Singapore, including those without traditional metabolic risk factors, according to local research.

Intrathecal onasemnogene abeparvovec (OAV101 IT), a one-time gene transfer therapy, significantly improves motor function in treatment-naïve patients with spinal muscular atrophy (SMA), as shown by the period 1 results of the phase III STEER study.